Oral GLP-1s and Thyroid Medication: The Absorption Question
Two of the most common prescriptions for a woman over 45 are levothyroxine and, increasingly, a GLP-1. Both are absorbed in the same stretch of gut. One of them slows the stomach down. And when the GLP-1 is a tablet or capsule rather than an injection, both want the same thing every morning: an empty stomach, plain water, and nothing else for a while.
This page is about what happens when they meet. It is written for oral semaglutide and applies equally to oral tirzepatide, which links here rather than repeating it.
What the label says
The Rybelsus label — the approved oral semaglutide — reports a drug-interaction study in which levothyroxine exposure rose by about a third when taken with oral semaglutide. The mechanism is thought to be delayed gastric emptying: the thyroid tablet sits in the stomach longer, dissolves more completely, and more of it is absorbed. The label's instruction is to monitor thyroid parameters in patients on both.
Injectable GLP-1s carry a general caution about oral medications and gastric emptying but no specific levothyroxine figure. The oral route is where the interaction is documented, because it is where the two drugs physically coincide.
Whether a compounded oral semaglutide or tirzepatide capsule behaves the same way is unknown — nobody has run the study — but the mechanism does not depend on the brand, and we treat the interaction as present.
Why a third matters
Levothyroxine has a narrow therapeutic window. Too little and the symptoms of hypothyroidism return; too much and a person becomes subtly hyperthyroid — palpitations, anxiety, sleep disruption, bone loss over time, and in older adults a real increase in atrial fibrillation risk. A third more exposure in someone who was well dosed is enough to tip them over, and the symptoms of over-replacement overlap, unhelpfully, with the early side effects of a GLP-1 and with perimenopause itself.
That overlap is why the interaction is missed. A woman who starts an oral GLP-1, develops palpitations and poor sleep, and puts it down to the new medication or to menopause may be mildly thyrotoxic — and the only way to know is a TSH.
The morning problem
Both drugs are taken first thing, fasting, with water, followed by a wait before food or other medications. They cannot both be first. Taken together, the interaction above applies; taken in sequence, the second one's absorption is compromised by the first's wait.
There is no elegant answer, and we do not publish a timing schedule here because the right arrangement depends on the person, the products and what the clinician managing the thyroid prefers. What we can say is that it is a known problem with known solutions, that it is a conversation to have before the first capsule, and that "I'll just take them together" is the option most likely to produce a wrong thyroid result.
For some patients, the honest resolution is that an oral GLP-1 is the wrong route, and the weekly injection — which has no morning ritual and no documented levothyroxine figure — is the better fit. That is a reasonable outcome of the conversation, not a failure of it.
What we do
We ask. Thyroid medication is on the assessment, and an oral GLP-1 is not prescribed to someone on levothyroxine without this interaction being discussed and the thyroid prescriber being aware.
We recheck TSH. A baseline before starting, and a repeat within the first two to three months — sooner if symptoms suggest over-replacement. The thyroid explainer covers what the numbers mean.
We watch for the overlap. Palpitations, tremor, heat intolerance, new anxiety or insomnia after starting an oral GLP-1 are a reason to check the thyroid, not only to blame the new drug.
We do not adjust the levothyroxine. That is the thyroid prescriber's decision, made on the TSH, and we make sure they have it.
Frequently asked questions
Yes, with monitoring. The Rybelsus label reports about a third more levothyroxine exposure when taken together and advises checking thyroid function. Your thyroid prescriber needs to know.
Slower gastric emptying keeps the levothyroxine tablet in the stomach longer, so more of it is absorbed.
It carries a general caution about oral medications, but the specific levothyroxine figure is from the oral product. The interaction is smaller or absent with the injection.
That is arranged individually with your clinicians. We do not publish a schedule, and taking them together is the option most likely to cause a problem.
Palpitations, tremor, heat intolerance, anxiety, insomnia — which overlap with GLP-1 side effects and perimenopause. A TSH resolves the question.
The mechanism is the same and we treat it as present, though the study was done with oral semaglutide.
Where this fits in your plan
The Semaglutide Oral Capsules and Tirzepatide Oral Capsules pages cover the products. A baseline panel with TSH, free T4 and free T3 comes first, and is repeated.
We measure first. Then we act.
References
- Rybelsus (semaglutide tablets) prescribing information — Section 7, Drug Interactions: levothyroxine; Section 12.3, Pharmacokinetics.
- Wegovy (semaglutide) tablets prescribing information, December 2025 — drug interactions.
- Jonklaas J et al. Guidelines for the Treatment of Hypothyroidism: prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement. Thyroid 2014;24:1670–1751 — levothyroxine absorption and monitoring.
- Biondi B, Cooper DS. Subclinical hyperthyroidism. NEJM 2018;378:2411–2419 — risks of over-replacement in older adults.
- Back toSemaglutide Oral Capsules
- Oral semaglutide vs Rybelsus and the Wegovy pillThree oral semaglutides now exist and only two have trials. How the Wegovy pill, Rybelsus and a compounded capsule differ in absorption, evidence and what they are for.Read
- Is it midlife, or is it your thyroid?Thyroid disease and the menopause transition share almost every symptom. The features that actually separate them, and why both can be true at once.Read
- Semaglutide injectionA GLP-1 receptor agonist that works with your body's appetite and blood-sugar signaling to support weight management.Read
How we write and review our content
ACT 2 Health provides clinician-led care. Treatments are available only to eligible patients following clinical evaluation and within applicable regulations. This content is educational and is not medical advice. Individual results vary.
All medical decisions are made solely by licensed healthcare professionals. Medications are prescribed only when medically necessary. GLP-1 medications are not suitable for everyone. Results may vary.
Compounded medication. Prepared by a licensed compounding pharmacy under a prescription written for you. Compounded medications are not FDA-approved, are not reviewed by the FDA for safety or effectiveness, and are not equivalent to or interchangeable with any branded product. Prescribed only when a licensed provider determines it is medically appropriate.
Care is delivered via telemedicine by healthcare professionals licensed in the state where the patient is located. Services are available only in states where our providers are licensed.